Sexual transmission of HIV-1

Antiviral Research

Volumn 85, Issue 1, 2010, Pages 276-285

  Fox, Julie ^a   Fidler, Sarah ^b  

^a Faculty of Medicine   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

HIV 1; Prevention; Risk behaviour; Sexual transmission

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; COPPER INTRAUTERINE DEVICE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MEDROXYPROGESTERONE ACETATE; MICROBICIDE; ORAL CONTRACEPTIVE AGENT; TENOFOVIR;

ANUS INTERCOURSE; BEHAVIOR CHANGE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CIRCUMCISION; CLINICAL TRIAL; DENDRITIC CELL; GENETIC POLYMORPHISM; GENITAL ULCER; HEALTH PROMOTION; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION RISK; INNATE IMMUNITY; MALE HOMOSEXUAL; MUCOSAL IMMUNITY; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SAFE SEX; SECONDARY PREVENTION; SEXUAL BEHAVIOR; SEXUAL EDUCATION; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; VIRION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS LOAD; VIRUS SHEDDING;

DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; SEXUALLY TRANSMITTED DISEASES, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 73549105254     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.10.012     Document Type: Review

References (177)

1. Abrahams M.R., et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J. Virol. 83 April (8) (2009) 3556-3567
2. Abu-Raddad L.J., et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV-1 prevalence in Africa. PLoS One 3 May (5) (2008) e2230
3. Abu-Raddad L.J., et al. No HIV-1 stage is dominant in driving the HIV-1 epidemic in sub-Saharan Africa. AIDS 22 May (9) (2008) 1055-1061
4. Ali S., et al. Secretor polymorphism and human immunodeficiency virus infection in Senegalese women. J Infect Dis. 181 (2000) 737-739
5. An P., et al. Modulating influence on HIV-1/AIDS by interacting RANTES gene variants. Proc. Natl. Acad. Sci. U.S.A. 99 15 (2002) 10002-10007
6. Asin S.N., et al. HIV type 1 infection in women: increased transcription of HIV type 1 in ectocervical tissue explants. J. Infect. Dis. 200 Sep (6) (2009) 965-972
7. Auvert B., et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV-1 infection risk: the ANRS 1265. Trial. PLoS Med. 2 (2005) e298
8. Baeten J.M., and Overbaugh J. Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Curr. HIV Res. January (1) (2003) 69-86
9. Baeten J.M., et al. The influence of hormonal contraceptive use on HIV-1-1 transmission and disease progression. Clin. Infect. Dis. 45 August (3) (2007) 360-369 (Epub 2007 June 18. Review)
10. Baggaley R.F., Garnett G.P., and Ferguson N.M. Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med. 3 (2006) e124
11. Bailey R., et al. Male circumcision for HIV-1 prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369 February (9562) (2007) 643-656
12. Barreiro P., del Romero J., Leal M., and Spanish HIV-Discordant Study Group. Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 43 3 (2006) 324-326
13. Bejrachandra S., Kitayaporn D., and Kaewkungwal J. HLA class II (DRB1, DQA1 and DQB1) allele and haplotype frequencies among HIV-1-infection discordant Thai couples. Asian Pac J Allergy Immunol. 22 2-3 (2004) 143-151
14. Belec, et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV-1) contrasts with normal or impaired IgA local response in HIV-1 infection. J. Infect. Dis. 172 (1995) 691-697
15. Biasin M., et al. .Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals. J. Infect. Dis. 195 7 (2007) 960-964
16. Bichacz K., et al. Syphilis increases HIV-1 viral load and decreases CD4 cell counts in HIV-1-infected patients wit new syphilis infections. AIDS 15 (2004) 2075-2079
17. Brenner B.G., et al. High rates of forward transmission events after acute/early HIV-1-1 infection. J. Infect. Dis. 195 April (7) (2007) 951-959
18. Brenner B.G., et al. Transmission networks of drug resistance acquired in primary/early stage HIV-1 infection. AIDS 18 (2008) 2509-2515
19. Brewer T., et al. Migration, ethnicity and environment: HIV-1 risk factors for women on the sugar cane plantations of the Dominican Republic. AIDS 12 14 (1998) 1879-1887
20. Brumme Z.L., et al. Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals. J. Infect. Dis. 192 August (3) (2005) 466-474
21. Burke J.G., et al. Intimate partner violence, substance use, and HIV-1 among low-income women: taking a closer look. Violence Women 11 September (9) (2005) 1140-1161
22. Buckheit R.W., Watson K.M., Morrow K.M., and Ham A.S. Development of topical microbicides to prevent the sexual transmission of HIV. Antivir. Res. 85 (2010) 142-158
23. Castilla J., et al. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J. Acquir. Immune Defic. Syndr. 40 1 (2005) 96-101
24. Clemetson D., et al. Detection of HIV-1 DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA 269 22 (1993) 2860-2864
25. Clerici M., et al. Serum IgA of HIV-1-exposed uninfected individuals inhibit HIV-1 through recognition of a region within the alpha-helix of gp41. AIDS 16 September (13) (2002) 1731-1741
26. Clerici M., et al. Cell mediated immune responses to human immunodeficiency virus (HIV-1) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1-1. J. Infect. Dis. 165 (1992) 1012-1019
27. Cohen M.S., Gay C., Kashuba A.D., Blower S., and Paxton L. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1-1. Ann. Intern. Med. 146 (2007) 591
28. Coombs R.W., et al. Lower genitourinary tract sources of seminal HIV-1. J. Acquir. Immune Defic. Syndr. 41 April (4) (2006) 430-438
29. Coombs R.W., et al. Recent observations on HIV-1 type-1 infection in the genital tract of men and women. AIDS 17 March (4) (2003) 455-480 (Review)
30. Coombs R.W., et al. Plasma viraemia in human immunodeficiency virus infection. NEJM 321 24 (1989) 1626-1631
31. Cooper E.R., et al. Women and Infants' Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-1-infected women and prevention of perinatal HIV-1-1 transmission. J. Acquir. Immune Defic. Syndr. 29 April (5) (2002) 484-494
32. Dean M., et al. Genetic restriction of HIV-1-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE. Science 273 (1996) 1856-1862
33. De Gruttola, et al. Infectiousness of HIV-1 between male homosexual partners. J. Clin. Epidemiol. 42 (1989) 849-856
34. Demirov D., Ono J., Orenstein J., et al. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1-1 budding by blocking late domain function. PNAS 99 (2002) 955-960
35. Detels R., et al. Resistance to HIV-1-1 may be genetically mediated. AIDS 10 (1996) 102-104
36. Devito C., et al. Mucosal and plasma IgA from HIV-1-exposed seronegative individuals neutralize a primary HIV-1-1 isolate. AIDS 14 September (13) (2000) 1917-1920
37. Devito C., et al. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. J. Acquir. Immune Defic. Syndr. 30 4 (2002) 413-420
38. Diem K., et al. Male genital tract compartmentalization of human immunodeficiency virus type 1 (HIV-1). AIDS Res. Hum. Retroviruses 24 April (4) (2008) 561-571
39. Dorrell L., et al. Absence of specific mucosal antibody responses in HIV-1 exposed uninfected sex workers from the Gambia. AIDS 4 9 (2000) 1117-1122
40. Duggal P., et al. Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans. Genes Immun. 4 4 (2003) 245-250
41. Dunkle K.L., Jewkes R.K., Brown H.C., et al. Gender-based violence, relationship power, and risk of HIV-1 infection in women attending antenatal clinics in South Africa. Lancet 363 9419 (2004) 1415-1421
42. Foresman L., et al. Neutralizing antibodies administered before, but not after, virulent SHIV-1 prevent infection in macaques. AIDS Res. Hum. Retroviruses 14 August (12) (1998) 1035-1043
43. Fox J., et al. Reductions in HIV-1 transmission risk behaviour following diagnosis of primary HIV-1 infection: a cohort of high-risk men who have sex with men. HIV-1 Med. 10 August (7) (2009) 432-438
44. Fraser C., et al. Variation in HIV-1-1 set point viral load: epidemiological analysis and an evolutionary hypothesis. PNAS 104 (2007) 17441-17446
45. Frater A.J., et al. Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts. J. Virol. 80 14 (2006) 7226-7234
46. Freeman E.E., et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20 1 (2006) 73-83 Review
47. García-Lerma J.G., et al. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med. 5 February (2) (2008) e28
48. Garrus J.E., et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107 (2001) 55-65
49. Gay C.L., and Cohen M.S. Antiretrovirals to prevent HIV-1 infection: pre- and postexposure prophylaxis. Curr. Infect. Dis. Rep. 10 July (4) (2008) 323-331
50. Geijtenbeek T.B., et al. Identification of DC-SIGN a novel dendritic cell specific ICAM-3 receptor that supports primary immune responses. Cell 100 5 (2000) 575-585
51. Geijtenbeek T.B., and van Kooyk Y. DC-SIGN: a novel HIV-1 receptor on DCs that mediates HIV-1-1 transmission. Curr. Top. Microbiol. Immunol. 276 (2003) 31-54 (Review)
52. Giesecke J., et al. Partner notification as a tool for research in HIV-1 epidemiology: behaviour change, transmission risk and incidence trends. AIDS 6 1 (1992) 101-107 27; 4(3)
53. Gilks C.F., et al. The WHO public-health approach to antiretroviral treatment against HIV-1 in resource-limited settings. Lancet 368 (2006) 505-510
54. Goh W.C., et al. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects. J. Infect. Dis. 179 3 (1999) 548-557
55. Goonetilleke N., et al. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1-1 Gag coupled to CD8+ T-cell epitopes. J. Virol. 80 May (10) (2006) 4717-4728
56. Gorbach P.M., and Holmes K.K. Transmission of STIs/HIV-1 at the partnership level: beyond individual-level analyses. J. Urban Health 80 4 (Suppl. 3) (2003) 15-25
57. Granich R.M., et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373 January (9657) (2009) 48-57
58. Gray R.H., et al. Empirical observations underestimate the proportion of HIV-1 infections attributable to sexually transmitted diseases in Mwanza and Rakai STD treatment trials: simulation results. Sex Transm. Dis. 34 1 (2007 Jan) 61
59. Gray, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual. HIV-1-1 discordant couples in Rakai, Uganda. Lancet 357 9263 (2001) 1149-1153
60. Gray R.H., et al. Male circumcision for HIV-1 prevention in men in Rakai, Uganda a randomised trial. Lancet 369 February (9562) (2007) 657-666
61. Gray R.H., et al. Increased risk of incident HIV-1 during pregnancy in Rakai, Uganda: a prospective study. Lancet 366 9492 (2005) 1182-1188
62. Gray R.H., and Wawer M.J. Reassessing the hypothesis on STI control for HIV-1 prevention. Lancet. 371 June (9630) (2008) 2064-2065
63. Gregson S., et al. Impact and process evaluation of integrated community and clinic-based HIV-1-1 control: a cluster-randomised trial in eastern Zimbabwe. PLoS Med. March (2007)
64. Grant R.M., et al. Infectivity of the human immunodeficiency virus: estimates from a prospective study of homosexual men. J. Infect. Dis. 156 1 (1987) 189-193
65. Grosskurth H., et al. Impact of improved treatment of sexually transmitted diseases on HIV-1 infection in rural Tanzania: randomised controlled trial. Lancet 346 8974 (1995) 530-536
66. Gunthard H.F., et al. Residual human immunodeficiency virus Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. J. Infect. Dis. 183 (2001) 1318-1327
67. Gupta P., et al. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 76 October (19) (2002) 9868-9876
68. Hanenberg R.S., et al. Impact of Thailand's HIV-1 control programme as indicated by the decline of sexually transmitted diseases. Lancet 344 8917 (1994) 243-245
69. HIV-1 prevention trials network. HPTN 052: a randomized placebo-controlled trial to evaluate the effectiveness of antiretroviral therapy to prevent the sexual transmission of HIV-1 in serodiscordant couples. http://www.hptn.org/research_studies/hptn052.asp.
70. Hira S.K., et al. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. Int. J. STD AIDS 8 4 (1997) 243-250
71. Huang Y., et al. The role of a mutant CCR5 allele in HIV-1-1 transmission and disease progression. Nat. Med. 2 (1996) 1240-1243
72. Hayes, et al. The cofactor effect of genital ulcers in the per-exposure risk of HIV-1 transmission in sub-Saharan Africa. J. Trop. Hyg. 98 (1995) 108
73. Hester R., and Kennedy S. Candida infection as a risk factor for HIV-1 transmission. J. Womens Health (Larchmt) 12 5 (2003) 487-494
74. Hladik F., et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26 (2007) 257-270
75. Hollingsworth T.D., et al. HIV-1-1 transmission, by stage of infection. J. Infect. Dis. 198 (2008) 687-693
76. Jameson B., et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 76 February (4) (2002) 1866-1875
77. Jacquez J.A., et al. Role of the primary infection in epidemics of HIV-1 infection in gay cohorts. J. Acquir. Immune Defic. Syndr. 7 November (11) (1994) 1169-1184
78. Jewkes R., et al. Impact of stepping stones on incidence of HIV-1 and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ 337 (2008) a506
79. Jewkes R., et al. A cluster randomized-controlled trial to determine the effectiveness of Stepping Stones in preventing HIV-1 infections and promoting safer sexual behaviour amongst youth in the rural Eastern Cape, South Africa: trial design, methods and baseline findings. Trop. Med. Int. Health 11 (2006) 3-16
80. Kalichman S.C., et al. Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex Transm. Dis. 35 January (1) (2008) 55-60 (Review)
81. Kaslow R.A., et al. Influence of host genetic variation on susceptibility to HIV type 1 infection. J. Infect. Dis. 191 February (Suppl. 1) (2005) S68-S77 (Review)
82. Kaul R., et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 291 (2004) 2555-2562
83. Kaul R., et al. HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis. AIDS 18 October (15) (2004) 2087-2089
84. Kaul R., et al. CD8(+) lymphocytes respond to different HIV-1 epitopes in seronegative and infected subjects. J. Clin. Invest. 107 May (10) (2001) 1303-1310
85. Kaul R., et al. HIV-1 specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J. Immunol. 164 February (3) (2000) 1602-1611
86. Keele, et al. Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1-1 infection. PNAS 105 21 (2008) 7552-7557
87. Korenromp E.L., et al. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV-1 infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J. Infect. Dis. 191 February (Suppl. 1) (2005) S168-S178
88. Kostrikis L.G., et al. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J. Virol. 73 12 (1999) 10264-10271
89. Krieger, et al. Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. JID 163 2 (1991) 386-388
90. Law M.G., et al. Modelling the effect of combination antiretroviral treatments on HIV-1 incidence. AIDS 15 (2001) 1287-1294
91. Lazzarin A., et al. Man-to-woman sexual transmission of the human immunodeficiency virus. Risk factors related to sexual behavior, man's infectiousness, and woman's susceptibility. Arch. Intern. Med. 151 12 (1991) 2411-2416
92. Lee H.Y., et al. Modeling sequence evolution in acute HIV-1 infection. J. Theor. Biol. 261 Nov (2) (2009) 341-360
93. Levy J.A. The transmission of HIV-1 and factors influencing progression to AIDS. Am. J. Med. 95 1 (1993) 86-100 (Review)
94. Lorello G., et al. Discordance in HIV-1-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma. HIV-1 Med. June (8) (2009)
95. Liu C., et al. Lack of associations between HLA class II alleles and resistance to HIV-1 infection among white, non-Hispanic homosexual men. J. Acquir. Immune Defic. Syndr. 37 October (2) (2004) 1313-1317
96. Louisirirotchanakul S., et al. Genetic analysis of HIV-1 discordant couples in Thailand: association of CCR2 64I homozygosity with HIV-1-negative status. J. Acquir. Immune Defic. Syndr. 29 3 (2002) 314-315
97. Margolis L., and Shattock R. Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?. Nat. Rev. Microbiol. 4 April (4) (2006) 312-317
98. Mayer K., et al. The social ecology of HIV-1/AIDS. Med. Clin. North Am. 92 (2008) 1363-1375
99. Macdonald N., et al. Factors associated with HIV-1 seroconversion in gay men in England at the start of the 21st century. Sex Transm. Infect. 84 1 (2008) 8-13
100. MacDonald K.S., et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J. Infect. Dis. 177 March (3) (1998) 551-556
101. Malamba S.S., et al. Couples at risk: HIV-1-1 concordance and discordance among sexual partners receiving voluntary counseling and testing in Uganda. J. Acquir. Immune Defic. Syndr. 39 5 (2005) 576-580
102. Mastro T.D., and Kitayaporn D. HIV-1 type 1 transmission probabilities: estimates from epidemiologic studies. AIDS Res. Hum. Retrovirol. 14 Suppl 3 (1998) 223-227
103. Marx P.A., et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 2 October (10) (1996) 1084-1089
104. Malamba S.S., et al. Couples at risk: HIV-1-1 concordance and discordance among sexual partners receiving voluntary counseling and testing in Uganda. J. Acquir. Immune Defic. Syndr. 39 August (5) (2005) 576-580
105. Mbopi-Keou F., et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J. Infect. Dis. 182 (2000) 1090-1096
106. Mbopi-Kéou F.X., et al. Genital shedding of herpes simplex virus-2 DNA and HIV-1-1 RNA and proviral DNA in HIV-1-1- and herpes simplex virus-2-coinfected African women. J. Acquir. Immune Defic. Syndr. 33 June (2) (2003) 121-124 24
107. McClelland R.S., et al. Infection with Trichomonas vaginalis increases the risk of HIV-1-1 acquisition. J. Infect. Dis. 195 5 (2007) 698-702
108. McDermott D.H., Colla J.S., Kleeberger C.A., et al. Genetic polymorphism in CX3CR1 and risk of HIV-1 disease. Science 290 December (5499) (2000) 2031
109. MacDonald K.S., et al. The HLA A2/6802 supertype is associated with reduced risk of perinatal human immunodeficiency virus type 1 transmission. J. Infect. Dis. 183 3 (2001) 503-506
110. Medical Development Programme. http://www.mdp.mrc.ac.uk/downloads/MoreMDPinfo_18Feb08_v0%202_final.pdf (accessed August 2009).
111. Meng G., et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1-1 to CCR5+ cells. Nat. Med. 8 February (2) (2002) 150-156
112. Mestecky J., et al. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-1-type 1-infected individuals. AIDS Res. Hum. Retroviruses 20 9 (2004) 972-988
113. Miller C.J., et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 9 14 (2005) 9217-9227
114. Mills E., et al. Male circumcision for the prevention of heterosexually acquired HIV-1 infection: a meta-analysis of randomized trials involving 11,050 men. HIV-1 Med. 9 (2008) 332-335
115. Modi W.S., et al. MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1-1 transmission. AIDS 17 16 (2003) 2357-2365
116. Montoya C.J., Rugeles M.T., et al. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin. Immunol. 120 August (2) (2006) 138-146
117. Moriuchi M., et al. Herpes simplex virus infection induces replication of human immunodeficiency virus type 1. Virology 278 2 (2000) 534-540
118. Morrison C.S., et al. Pregnancy and the risk of HIV-1-1 acquisition among women in Uganda and Zimbabwe. AIDS 21 May (8) (2007) 1027-1034
119. Morrison C.S., et al., Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV) Study Group. Hormonal contraception and the risk of HIV acquisition. AIDS 21 1 (2007) 85-95
120. Mostad S.B., and Kreiss J.K. Shedding of HIV-1 in the genital tract. AIDS 19 (1996) 1305-1315
121. Myer L., et al. Bacterial vaginosis and susceptibility to HIV-1 infection in South African women: a nested case-control study. J. Infect. Dis. 192 8 (2005) 1372-1380
122. Münch J., et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131 December (6) (2007) 1059-1071
123. Nguyen M., et al. HIV-1-specific antibodies but not T-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia. J. Acquir. Immune Defic. Syndr. 42 August (4) (2006) 412-419
124. Nicolosi A., et al. The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Epidemiology 5 (1994) 570-575
125. O'Brien S.J., and Nelson G.W. Human genes that limit AIDS. Nat. Genet. 36 6 (2004) 565-574 (Review)
126. Paltiel A.D., et al. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin. Infect. Dis. 48 Mar (6) (2009) 806-815
127. Patterson, et al. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridisation and flow cytometry. Science 260 5110 (1993) 976-979
128. Pao D., et al. Transmission of HIV-1-1 during primary infection: relationship to sexual risk and sexually transmitted infections. AIDS 19 January (1) (2005) 85-90
129. Peng G., Lei K.J., Jin W., Greenwell-Wild T., and Wahl S.M. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1-1 activity. J. Exp. Med. 203 January (1) (2006) 41-46
130. Pilcher C., et al. Brief but efficient: acute HIV-1 infection and the sexual transmission of HIV-1. JID 189 (2004) 1785-1792
131. Pilcher C.D., et al. Amplified transmission of HIV-1-1: comparison of HIV-1-1 concentrations in semen and blood during acute and chronic infection. AIDS 21 August (13) (2007) 1723-2358
132. Pinkerton S.D. How many sexually-acquired HIV-1 infections in the USA are due to acute-phase HIV-1 transmission?. AIDS 21 July (12) (2007) 1625-1629
133. Pinkerton S.D., et al. Model-based evaluation of HIV-1 prevention interventions. Eval. Rev. 22 (1998) 155-157
134. Pinto L., et al A., et al. ENV-specific cytotoxic T lymphocyte responses in HIV-1 seronegative health care workers occupationally exposed to HIV-1-contaminated body fluids. J. Clin. Invest. 96 2 (1995) 867-876
135. Quinn T.C. Circumcision and HIV-1 transmission. Curr. Opin. Infect. Dis. 20 (2007) 33-38
136. Quinn T., et al., Rakai Project Study Group. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N. Engl. J. Med. 342 13 (2000) 921-929
137. Read S.E., et al. Transplacental and autologous HIV-1-IgA antibodies in babies born to seropositive women. American Pediatric Association and Society for Pediatric Research annual meeting, 1996, vol. 7 (No. August (4)). Washington, DC, May 6-10. Pediatr. AIDS HIV-1 Infect. (1996) 284
138. Roos M.T., et al. Viral phenotype and immune response in primary human immunodeficiency virus infection. J. Infect. Dis. 165 March (3) (1992) 427-432
139. Ravet S., et al. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-1-exposed uninfected individuals. Blood 109 10 (2007) 4296-4305
140. Reynolds S.J., et al. Recent herpes simplex virus type 2 and the risk of HSV-1 in India. JID 187 (2004) 1513-1521
141. Rowland Jones S., et al. The role of cytotoxic T-cells in HIV-1 infection. Dev. Biol. Standards 92 (1998) 209-214
142. Royce R.A., et al. Sexual transmission of HIV-1. NEJM 336 (1997) 1072-1078
143. Ryder R.W., et al. Pregnancy and HIV-1 incidence in 178 married couples with discordant HIV-1-1 serostatus: additional experience at an HIV-1-1 counselling centre in the Democratic Republic of the Congo. Trop. Med. Int. Health 5 7 (2000) 482-487
144. Salazar-Gonzalez J.F., et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 206 6 (2009 Jun) 1273-1289
145. Samson M., et al. Resistance to HIV-1-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 (1996) 722-725
146. Saracco A., et al. Man-to-woman sexual transmission of HIV-1: longitudinal study of 343 steady partners of infected men. J. Acquir. Immune Defic. Syndr. 6 5 (1993) 497-502
147. Sawires S.R., et al. Male circumcision and HIV-1/AIDS: challenges and opportunities. Lancet 369 (2007) 708-713
148. Sawyer S.L., Wu L.I., Akey J.M., Emerman M., and Malik H.S. High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans. Curr. Biol. 16 January (1) (2006) 95-100
149. Shalekoff S., et al. Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers. AIDS 27 April (7) (2009) 789-798
150. Shattock R.J., and Moore J.P. Inhibiting sexual transmission of HIV-1-1 infection. Nat. Rev. Microbiol. 1 October (1) (2003) 25-34 (Review)
151. Sheffield J.S., et al. Effect of genital ulcer disease on HIV-1-1 coreceptor expression in the female genital tract. J. Infect. Dis. 196 November (10) (2007) 1509-1516
152. Shibata R., et al. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5 February (2) (1999) 204-210
153. Siriwasin W., et al., Bangkok Collaborative Perinatal HIV-1 Transmission Study Group. HIV-1 prevalence, risk, and partner serodiscordance among pregnant women in Bangkok. JAMA 280 July (1) (1998) 49-54
154. Stall R.D., et al. The gay'90s: a review of research in the, 1990s on sexual behaviour and HIV-1 risk among men who have sex with men. AIDS 14 Suppl. 3 (2000) S101-S114
155. Stremlau M., et al. The cytoplasmic body component TRIM5alpha restricts HIV-1-1 infection in Old World monkeys. Nature 427 February (6977) (2004) 848-853
156. Sugaya M., et al. HIV-1-infected Langerhans cells preferentially transmit virus to proliferating autologous CD4+ memory T cells located within Langerhans cell-T cell clusters. J. Immunol. 172 February (4) (2004) 2219-2224
157. Suy A., et al. Immunological profile of heterosexual highly HIV-1-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation. J. Infect. Dis. 196 October (8) (2007) 1191-1201
158. Tang J., et al. HLA-DRB1 and -DQB1 alleles and haplotypes in Zambian couples and their associations with heterosexual transmission of HIV-1 type 1. J. Infect. Dis. 189 May (9) (2004) 1696-1704
159. Trecarichi E.M., et al. Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1-1 exposed uninfected individuals. AIDS Res. Ther. 3 (2006) 22
160. Truong H.M., et al. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting?. Sex. Transm. Infect. 82 6 (2006) 461-466
161. UNAIDS, 2008. Report on the global HIV-1/AIDS epidemic. In: UNAIDS, 2008.
162. Van Der Pol B., et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J. Infect. Dis. 197 4 (2008) 548-554
163. Velasco-Hernandez J.X., Gershengorn H.B., and Blower S.M. Could widespread use of combination antiretroviral therapy eradicate HIV-1 epidemics?. Lancet Infect. Dis. 2 (2002) 487-493
164. Vernazza, et al. Les personnes seropositives ne souffrant d'aucune autre MST et suivant un traitment antiretroviral efficace transmettent pas le VIH par voie sexuelle. Bulletin des medecins suisses 89 5 (2008) 18-21
165. Wang C., et al. Risk of HIV-1 infection in oral contraceptive pill users: a meta-analysis. J. Acquir. Immune Defic. Syndr. 21 1 (1999) 51-58
166. Wawer M.J., et al. Circumcision in HIV-1-infected men and its effect on HIV-1 transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet 374 July (9685) (2009) 229-237
167. Wawer M.J., et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1-1 infection, in Rakai, Uganda. J. Infect. Dis. 191 May (9) (2005) 1403-1409
168. Wawer M.J., et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet 353 (1999) 525-535
169. Weiss H.A. Male circumcision as a preventive measure against HIV-1 and other sexually transmitted diseases. Curr. Opin. Infect. Dis. 20 (2007) 66-72 -10
170. White R.G., et al. Treating curable sexually transmitted infections to prevent HIV-1 in Africa: still an effective control strategy?. J. Acquir. Immune Defic. Syndr. 47 March (3) (2008) 346-353
171. White R.G., et al. Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV-1/sexually transmitted disease intervention trials? A modeling study. J. Acquir. Immune Defic. Syndr. 37 4 (2004) 1500-1513
172. Wilson D.P., et al. Relation between HIV-1 viral load and infectiousness: a model-based analysis. Lancet 372 July (9635) (2008) 314-320
173. Xiridou M., et al. Primary HIV-1 infection as source of HIV-1 transmission within steady and casual partnerships among homosexual men. AIDS 18 June (9) (2004) 1311-1320
174. Yap M.W., Nisole S., and Stoye J.P. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1-1 restriction. Curr. Biol. 15 January (1) (2005) 73-78
175. Yamamoto T., et al. Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is determined by the T cell activation state. PLoS Pathog. 5 January (1) (2009) e1000279
176. Zaitseva, et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for primary infection. Nat. Med. 3 12 (1997) 1369-1375
177. Zhu, et al. Genetic and phenotypic characterisation of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalisation and selection during sexual transmission. J. Virol. 70 (1996) 3098-3107